These results confirmed our hypothesis that Cucurbitacin E inhibits IL-1β-induced chondrocyte inflammation and cartilage degeneration in osteoarthritis by inhibiting the PI3K/Akt pathway. Here, AKT1 is linked to osteoarthritis.